• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国一项新型低剂量口服避孕药多中心试验的分析

Analysis of a multicentre trial of a new low-dose oral contraceptive in Great Britain.

作者信息

Bye P G

出版信息

Acta Obstet Gynecol Scand Suppl. 1976;54:61-6. doi: 10.3109/00016347609156450.

DOI:10.3109/00016347609156450
PMID:788447
Abstract

An oral contraceptive containing D-norgestrel 150 mug. and ethinol oestradiol 30 mug. (Neovletta) was tested in 682 British women during more than 6,000 cycles. The pregnancy rate was 0.2 per 100 woman-years with the exclusion of pregnancies that followed admitted errors of tablet-taking, and 0.8 per 100 woman-years when they were included. 92.2 per cent of cycles were within 28 +/- 3 days. withdrawal-bleeding was missed in 3.3 per cent of cycles. Spotting occurred in 9.3 per cent of cycles and breakthrough bleeding in 5.8 per cent. Total bleeding averaged 4.71 days per cycle. Concurrent symptoms likely to be attributable to the pill were few and only 10.3 per cent of subjects withdrew because of them. It can be concluded that this formulation is extremely well tolerated and highly effective.

摘要

一种含有150微克炔诺孕酮和30微克炔雌醇的口服避孕药(诺美婷)在682名英国女性中进行了超过6000个周期的测试。排除因承认漏服药片后发生的妊娠,妊娠率为每100妇女年0.2例;若将这些妊娠包括在内,则为每100妇女年0.8例。92.2%的周期在28±3天内。3.3%的周期出现漏撤药性出血。9.3%的周期出现点滴出血,5.8%的周期出现突破性出血。总出血时间平均每个周期为4.71天。可能归因于该药的并发症状很少,只有10.3%的受试者因此停药。可以得出结论,这种配方耐受性极佳且效果显著。

相似文献

1
Analysis of a multicentre trial of a new low-dose oral contraceptive in Great Britain.英国一项新型低剂量口服避孕药多中心试验的分析
Acta Obstet Gynecol Scand Suppl. 1976;54:61-6. doi: 10.3109/00016347609156450.
2
Four years overall experience with a new low estrogen -- low progestogen oral contraceptive.新型低雌激素 - 低孕激素口服避孕药的四年总体使用经验。
Acta Obstet Gynecol Scand Suppl. 1976;54:67-70. doi: 10.3109/00016347609156451.
3
Preliminary results from a swedish multicenter trial of a new low dose combined oral contraceptive.一项关于新型低剂量复方口服避孕药的瑞典多中心试验的初步结果。
Acta Obstet Gynecol Scand Suppl. 1976;54:71-5. doi: 10.3109/00016347609156452.
4
A new ultra-low-dose combination oral contraceptive.一种新型超低剂量复方口服避孕药。
J Reprod Med. 1983 Jan;28(1 Suppl):81-4.
5
Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.年轻女性使用三相口服避孕药(“Trinordiol”)的临床经验。
Curr Med Res Opin. 1983;8(6):395-404. doi: 10.1185/03007998309111745.
6
Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.左炔诺孕酮和炔雌醇以一种三相(Trionetta)和一种单相(Neovletta)剂型给药时的避孕可接受性比较。
Contraception. 1983 May;27(5):439-52. doi: 10.1016/0010-7824(83)90041-0.
7
Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.两种口服避孕药、疗效、血清蛋白与脂质代谢。一项关于三相片和固定剂量复方制剂的多中心对比研究。
Contraception. 1982 Sep;26(3):229-43. doi: 10.1016/0010-7824(82)90072-5.
8
Clinical experience with ethinyl estradiol and d-norgestrel as an oral contraceptive.炔雌醇和d-炔诺孕酮作为口服避孕药的临床经验。
Fertil Steril. 1975 Mar;26(3):283-8. doi: 10.1016/s0015-0282(16)40998-2.
9
Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.一项关于含有炔雌醇和去氧孕烯的单相口服避孕药的多中心试验。
Acta Obstet Gynecol Scand. 1988;67(2):171-4. doi: 10.3109/00016348809004193.
10
The 150/30 formulation. Experience in the United Kingdom.
J Reprod Med. 1983 Jan;28(1 Suppl):66-70.